Literature DB >> 467606

Lymphatic metastasis of tumour; persistent transport of cells.

J Carr, I Carr, B Dreher, C R Franks.   

Abstract

A model of lymphatic metastasis established by injecting Walker rat carcinoma cells into the rat footpad was used to study the output of tumour cells from the footpad. The lymphatic efferent from the footpad was cannulated in a group of rats with advanced neoplasm; it was shown that the output of tumour cells was continuous over periods up to 90 min and ranged from 10(2)-10(5) cells/min.

Entities:  

Mesh:

Year:  1979        PMID: 467606     DOI: 10.1007/bf01968276

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  4 in total

Review 1.  Lymphatic invasion and metastasis.

Authors:  C van de Velde; I Carr
Journal:  Experientia       Date:  1977-07-15

2.  Lymphatic metastasis and its inhibition: an experimental model.

Authors:  I Carr; F McGinty
Journal:  J Pathol       Date:  1974-06       Impact factor: 7.996

3.  Lymhatic metastasis of transplantable animal neoplasms.

Authors:  I Carr; F McGinty; C Potter; S Westby
Journal:  Experientia       Date:  1974-02-15

4.  The fine structure of neoplastic invasion: invasion of liver, skeletal muscle and lymphatic vessels by the Rd/3 tumour.

Authors:  I Carr; F McGinty; P Norris
Journal:  J Pathol       Date:  1976-02       Impact factor: 7.996

  4 in total
  3 in total

1.  Establishment and characterization of cell lines from the Walker carcinoma 256 able to grow in suspension culture and deficient in thymidine kinase.

Authors:  F Arvelo; A Yabrudi; M E Delgado; N González-Cadavid
Journal:  In Vitro       Date:  1984-07

Review 2.  Experimental systems for analysis of the malignant phenotype.

Authors:  G Poste
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

3.  The relationship between lymphogenous and hematogenous metastasis in rats bearing the MT-100-TC mammary carcinoma.

Authors:  P M Ward; L Weiss
Journal:  Clin Exp Metastasis       Date:  1989 May-Jun       Impact factor: 5.150

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.